Literature DB >> 26092252

Recurrent Hemarthrosis Following Knee Arthroplasty Treated with Arterial Embolization.

Zachary D Weidner1, William G Hamilton1, John Smirniotopoulos2, Sandeep Bagla3.   

Abstract

Recurrent hemarthrosis is an uncommon but troublesome complication following knee arthroplasty. This study reports the results for 13 patients with spontaneous recurrent hemarthrosis after knee arthroplasty treated with arterial embolization. The average interval between arthroplasty and embolization was 47 months (range, 2-103 months), and the average time from onset of hemarthrosis to embolization was 4.1 months (range, 1-11 months). Geniculate arterial embolization lead to resolution of hemarthrosis in 12 of 13 patients (92.3%). The one clinical failure likely represented a case of misdiagnosed periprosthetic joint infection. Two patients experienced transient cutaneous ischemia related to distal particulate embolization that resolved spontaneously. Selective geniculate arterial embolization is an effective and safe treatment modality for recurrent hemarthrosis after knee arthroplasty.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  complications; embolization; recurrent hemarthrosis; total knee arthroplasty; unicompartmental knee arthroplasty

Mesh:

Year:  2015        PMID: 26092252     DOI: 10.1016/j.arth.2015.05.028

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  10 in total

Review 1.  Current Concepts and Future Directions of Minimally Invasive Treatment for Knee Pain.

Authors:  Daryl T Goldman; Rachel Piechowiak; Daniel Nissman; Sandeep Bagla; Ari Isaacson
Journal:  Curr Rheumatol Rep       Date:  2018-07-23       Impact factor: 4.592

2.  Quantitative analysis of the perimeniscal position of the inferior lateral genicular artery (ILGA): magnetic resonance imaging study.

Authors:  Jiwon Park; Sang Soo Lee; Tae Woo Kim
Journal:  Surg Radiol Anat       Date:  2018-04-24       Impact factor: 1.246

3.  Treatment of Recurrent Hemarthrosis after Total Knee Arthroplasty.

Authors:  Ju-Hyung Yoo; Hyun-Cheol Oh; Sang-Hoon Park; Sanghyeon Lee; Yunjae Lee; Seong-Hun Kim
Journal:  Knee Surg Relat Res       Date:  2018-06-01

4.  Genicular artEry embolizatioN in patiEnts with oSteoarthrItiS of the Knee (GENESIS) Using Permanent Microspheres: Interim Analysis.

Authors:  M W Little; M Gibson; J Briggs; A Speirs; P Yoong; T Ariyanayagam; N Davies; E Tayton; S Tavares; S MacGill; C McLaren; R Harrison
Journal:  Cardiovasc Intervent Radiol       Date:  2021-01-20       Impact factor: 2.740

Review 5.  Emerging Targets for the Treatment of Osteoarthritis: New Investigational Methods to Identify Neo-Vessels as Possible Targets for Embolization.

Authors:  Reza Talaie; Pooya Torkian; Alexander Clayton; Stephanie Wallace; Hoiwan Cheung; Majid Chalian; Jafar Golzarian
Journal:  Diagnostics (Basel)       Date:  2022-06-06

6.  Treatment of Recurrent Hemarthrosis Following Total Knee Arthroplasty Using Surgical Interventions.

Authors:  Keun Ho Park; Dong Hwi Kim; Se Woong Jang; Je Hong Ryu; Kang Yeol Ko
Journal:  Clin Orthop Surg       Date:  2021-04-01

7.  Spontaneous Recurrent Hemarthrosis Post Total Knee Arthroplasty Treated with Selective Embolization - A Case Report and Review of Literature.

Authors:  Prabhudev P Purudappa; Om P Sharma; Munis Ashraf; Senthil N Sambandam
Journal:  J Orthop Case Rep       Date:  2019

8.  Successful Selective Embolization for Recurrent Hemarthrosis after Knee Arthroplasty.

Authors:  Cristian Barrientos; Maximiliano Barahona; Tomas Cermenati; Rodrigo Wulf; Jaime Hinzpeter
Journal:  Case Rep Orthop       Date:  2019-12-05

9.  Recurrent Hemarthrosis After Total Knee Arthroplasty.

Authors:  Samuel Seow Zi Jie; Adrian Lau Cheng Kiang; Dave Lee Yee Han
Journal:  Arthroplast Today       Date:  2021-06-01

10.  Embolization for intractable spontaneous hemarthrosis of the knee joint in the elderly patient: Case report.

Authors:  Suk Kyoon Song; Seung Bum Chae; Dae Won Kang; Won Kee Choi
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.